These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis. Suwattee P; Chow S; Berg BC; Warshaw EM Arch Dermatol; 2008 Jan; 144(1):123-5. PubMed ID: 18209189 [No Abstract] [Full Text] [Related]
3. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Lipworth AD; Robert C; Zhu AX Oncology; 2009; 77(5):257-71. PubMed ID: 19923864 [TBL] [Abstract][Full Text] [Related]
4. [Hand-foot syndrome after administration of tyrosinkinase inhibitors]. Bednaríková D; Kocák I Klin Onkol; 2010; 23(5):300-5. PubMed ID: 21061680 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib. McLellan B; Kerr H Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797 [TBL] [Abstract][Full Text] [Related]
6. Blackberry-induced hand-foot skin reaction to sunitinib. Boone SL; Jameson G; Von Hoff D; Lacouture ME Invest New Drugs; 2009 Aug; 27(4):389-90. PubMed ID: 18998055 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553 [TBL] [Abstract][Full Text] [Related]